Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis

Clinical Infectious Diseases

Volumn 36, Issue 1, 2003, Pages 53-59

  Cosgrove, Sara E ^a,c   Sakoulas, George ^a   Perencevich, Eli N ^a   Schwaber, Mitchell J ^a   Karchmer, Adolf W ^a   Carmeli, Yehuda ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN;

ARTICLE; BACTEREMIA; BIBLIOGRAPHIC DATABASE; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SENSITIVITY; EVIDENCE BASED MEDICINE; HUMAN; INFORMATION PROCESSING; LANGUAGE; MEDLINE; META ANALYSIS; MODEL; MORTALITY; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PUBLICATION; RISK; STAPHYLOCOCCUS AUREUS;

BACTEREMIA; COHORT STUDIES; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0037235347     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/345476     Document Type: Article

References (50)

1. Acar JF. Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis 1997; 24(Suppl 1):S17-8.
2. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27:520-32.
3. Cluff LE, Reynolds RC, Page DL, Breckenridge JL. Staphylococcal bacteremia and altered host resistance. Ann Intern Med 1968; 69:859-73.
4. Julander I. Unfavourable prognostic factors in Staphylococcus aureus septicemia and endocarditis. Scand J Infect Dis 1985; 17:179-87.
5. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk [see comments]. JAMA 1998; 279:593-8.
6. McClelland RS, Fowler VG Jr, Sanders LL, et al. Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med 1999; 159:1244-7.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-88.
8. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
9. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-101.
10. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19:32-7.
11. Craven DE, Kollisch NR, Hsieh CR, Connolly MG Jr, McCabe WR. Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis 1983; 147:137-43.
12. Cunney RJ, McNamara EB, al Ansari N, Smyth EG. Community and hospital acquired Staphylococcus aureus septicaemia: 115 cases from a Dublin teaching hospital. J Infect 1996; 33:11-3.
13. Fowler VG Jr, Sanders LL, Kong LK, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up [see comments]. Clin Infect Dis 1999; 28:106-14.
14. French GL, Cheng AF, Ling JM, Mo P, Donnan S. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 1990; 15:117-25.
15. Gang RK, Sanyal SC, Bang RL, Mokaddas E, Lari AR. Staphylococcal septicaemia in burns. Burns 2000; 26:359-66.
16. Gentry CA, Rodvold KA, Novak RM, Hershow RC, Naderer OJ. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis. Pharmacotherapy 1997; 17:990-7.
17. Gosbell IB, Duggan D, Breust M, Mulholland K, Gottlieb T, Bradbury R. Infection associated with central venous catheters: a prospective survey. Med J Aust 1995; 162:210-3.
18. Grieble HG, Krause SL, Pappas SA, DiCostanzo MB. The prevalence of high-level methicillin resistance in multiply resistant hospital staphylococci. Medicine (Baltimore) 1981; 60:62-9.
19. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158:182-9.
20. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users: prognostic features in 102 episodes. Ann Intern Med 1992; 117:560-6.
21. Hershow RC, Khayr WF, Smith NL. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol 1992; 13:587-93.
22. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-55.
23. Inoue Y, Kohno S, Fujii T, et al. Clinical evaluation of catheter-related fungemia and bacteremia. Intern Med 1995; 34:485-90.
24. Kuikka A, Valtonen VV. Improved outcomes of Staphylococcus aureus bacteremia. Infect Dis Clin Pract 1994; 3:282-7.
25. Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis 1986; 8:374-96.
26. Lewis E, Saravolatz LD. Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control 1985; 13:109-14.
27. Marty L, Flahault A, Suarez B, Caillon J, Hill C, Andremont A. Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med 1993; 19:285-9.
28. Mizushima Y, Kawasaki A, Hirata H, et al. An analysis of bacteraemia in a university hospital in Japan over a 10-year period. J Hosp Infect 1994; 27:285-98.
29. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987; 9:891-907.
30. Mylotte JM, Aeschlimann JR, Rotella DL. Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infect Control Hosp Epidemiol 1996; 17:165-8.
31. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000; 31:1170-4.
32. Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994; 13:96-102.
33. Roghmann MC. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000; 160:1001-4.
34. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21:1417-23.
35. Selvey LA, Whitby M, Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol 2000; 21:645-8.
36. Soriano A, Martinez JA, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30:368-73.
37. Sorrell TC, Packham DR, Shanker S, Foldes M, Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97:344-50.
38. Tabak OF, Clark RA, Lepre D, Beilke M. Nosocomial central venous catheter-related infections in intensive care units. J La State Med Soc 1996; 148:399-402.
39. Topeli A, Unal S, Akalin HE. Risk factors influencing clinical outcome in Staphylococcus aureus bacteraemia in a Turkish University Hospital. Int J Antimicrob Agents 2000; 14:57-63.
40. Soriano A, Martinez JA, Mensa J, et al. Reply. Clin Infect Dis 2000; 31:1311-3.
41. McCabe W, Jackson G. Gram-negative bacteremia. Arch Intern Med 1962; 110:847-55.
42. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
43. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-36.
44. Fowler VG Jr, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997; 30:1072-8.
45. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990; 34:1227-31.
46. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991; 115:674-80.
47. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988; 109:619-24.
48. Allaouchiche B, Jaumain H, Zambardi G, Chassard D, Freney J. Clinical impact of rapid oxacillin susceptibility testing using a PCR assay in Staphylococcus aureus bactaeremia. J Infect 1999; 39:198-204.
49. Domaracki BE, Evans AM, Venezia RA. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci. Antimicrob Agents Chemother 2000; 44:1394-6.
50. Climo MW, Patron RL, Archer GL. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrob Agents Chemother 1999; 43:1747-53.